Showing 1 - 20 results of 26 for search 'N. V. Furman', query time: 0.04s Refine Results
  1. 1
    CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION

    CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION by N. V. Furman, S. S. Shmatova

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME

    ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME by O. V. Reshetko, R. M. Magdeev, N. V. Furman

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Plasma D-dimer level value in pulmonary artery thromboembolia diagnostics

    Plasma D-dimer level value in pulmonary artery thromboembolia diagnostics by N. V. Furman, A. R. Kiselev, P. Ya. Dovgalevsky

    Published 2006-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY

    THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY by O. V. Reshetko, N. V. Furman, R. M. Magdeev

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION

    PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION by N. V. Mikheeva, O. V. Reshetko, N. V. Furman

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA

    RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA by N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES

    CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES by P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE

    PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE by I. V. Graifer, O. V. Reshet'ko, N. V. Furman

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION

    UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION by E. A. Protasova, N. V. Furman, O. V. Reshet'ko

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE

    COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL... by L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

    RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID by N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE

    MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya

    Published 2017-03-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice

    High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in p... by N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova

    Published 2016-09-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015

    COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 by O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK

    INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK by N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)

    Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) by O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE

    PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE by P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION

    THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION by N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES

    PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES by O. V. Reshetko, N. V. Furman, R. M. Magdeev, Ya. P. Ya.P. Dovgalevskiy

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES

    ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES by Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: